Evidence map›Paper›PMID 39702303›Full record

ArticleBMC oral health2024

Characteristics of drugs with oral frailty patients among community pharmacy visitors: a cross-sectional study.

Ayako Maeda-Minami, Misuzu Takashima, Yukako Morisaki, Shunsuke Ehara, Seiichi Kato, Kazuhiro Saito, Tomokazu Tanaka, Yoshiaki Shikamura, Yasunari Mano

Abstract read
In one paragraph

Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayako Maeda-MinamiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Chiba, Noda, 278-8510, Japan. ayako.maeda@rs.tus.ac.jp.
Misuzu TakashimaFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Chiba, Noda, 278-8510, Japan.
Yukako MorisakiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Chiba, Noda, 278-8510, Japan.
Shunsuke EharaPinokio Pharmacy, Tochigi, Japan.
Seiichi KatoPinokio Pharmacy, Tochigi, Japan.
Kazuhiro SaitoPinokio Pharmacy, Tochigi, Japan.
Tomokazu TanakaPinokio Pharmacy, Tochigi, Japan.
Yoshiaki ShikamuraFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Chiba, Noda, 278-8510, Japan.
Yasunari ManoFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Chiba, Noda, 278-8510, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the rise in the older population, it has become important to understand the relationship between oral frailty and drug use to consider appropriate medical interventions and drug use for older persons.

objectiveTo clarify the relationship among oral frailty, drug use, and other patient backgrounds and to identify relevant factors using information from patient questionnaires and pharmacy medication history records.

methodsThis cross-sectional study involved community-dwelling older adults. Older adults aged ≥ 65 years who visited 44 pharmacies in Tochigi Prefecture, Japan, with their prescriptions between July 1 and September 10, 2021, and who were able to complete the questionnaire independently were eligible for the study. An oral Frailty Index-8 score ≥ 4 was used to define the oral frailty group, while a score of 0-3 was used to define the non-oral frailty group. A multivariate logistic regression analysis was conducted to identify relevant factors for oral frailty, with oral frailty as the dependent variable and items from the questionnaire and drug survey as independent variables.

resultsA total of 1,386 eligible participants were included in this study, and 761 (54.9%) had oral frailty. Multivariate logistic regression analysis showed that frailty, number of natural teeth (fewer than 20), and benzodiazepine use were significantly associated with oral frailty (p < 0.001, p < 0.001, and p = 0.037, respectively).

conclusionsOur results will provide evidence for community pharmacists to provide appropriate patient education, recommend consultations with dental care providers, and assist in community healthcare coordination.

Indexed as

FrailtyAgedAged, 80 and overCommunity Pharmacy ServicesCross-Sectional StudiesFemaleFrail ElderlyHumansIndependent LivingJapanMaleSurveys and QuestionnairesBenzodiazepinesOlder personsOral frailty

Identifiers

PMID39702303
PMCPMC11660500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.